Division of Colorectal Oncology, Department of Surgical Oncology, Tata Memorial Centre, Mumbai, India.
Eur J Surg Oncol. 2023 Jul;49(7):1307-1313. doi: 10.1016/j.ejso.2023.02.012. Epub 2023 Mar 3.
Although advances in treatment have improved sphincter-preservation rates in rectal cancer, the incidence of benign anastomotic strictures has also increased. This retrospective single-institution study sought to determine the incidence of benign anastomotic strictures and the factors associated with their successful resolution following treatment.
From January 2010 to December 2019, consecutive patients undergoing endoscopic dilatation and/or surgery for benign anastomotic strictures developing after radical sphincter-sparing resections for rectal cancer were evaluated. To model the relationship between outcomes and potential independent variables, sequential univariate and multivariate analyses were performed using binary logistic regression.
Of 2069 rectal cancer patients undergoing sphincter-preserving surgery, benign anastomotic strictures were identified in 110 (5.3%). Mean age was 48.2 ± 13.98 years; 73.6% were male. Distal tumor-extent was within 6 cm of the anal verge in 60%; 80.9% patients received neoadjuvant radiotherapy. Surgical approach in 71.8% was open, 74.5% being anterior or low anterior resections and 70.9% of anastomoses stapled. Covering stoma was performed in 91.8%. On follow-up, strictures of median length 4 cm were identified at median 3 cm from the anal verge. Endoscopic dilatation was offered in 89.1%, whereas 9.1% required redo-surgery. Overall, 49.1% experienced sustained stricture-resolution with dilatation and 45.4% required re-intervention. At last follow-up, 72.7% were stoma-free. On multivariate analysis, good performance status, absence of anastomotic leak, and short-segment strictures predicted successful stricture-resolution.
Endoscopic dilatation is an effective first-line therapy, with redo anastomosis used to salvage those failing conservative measures. Adverse performance status, anastomotic leak and greater stricture length may predict detrimental outcomes in terms of stricture resolution.
尽管治疗方法的进步提高了直肠癌保肛手术的保肛率,但良性吻合口狭窄的发生率也有所增加。本回顾性单中心研究旨在确定良性吻合口狭窄的发生率以及治疗后吻合口狭窄成功缓解的相关因素。
2010 年 1 月至 2019 年 12 月,连续评估接受内镜扩张和/或手术治疗因直肠癌保肛手术后发生良性吻合口狭窄的患者。为了建立结局与潜在独立变量之间的关系,采用二元逻辑回归对连续单变量和多变量进行分析。
在 2069 例接受保肛手术的直肠癌患者中,发现 110 例(5.3%)发生良性吻合口狭窄。平均年龄为 48.2±13.98 岁;73.6%为男性。远端肿瘤位于肛缘 6cm 以内的占 60%;80.9%的患者接受了新辅助放疗。71.8%的手术方式为开放性,74.5%为前侧或低位前切除术,70.9%的吻合口采用吻合器吻合。91.8%的患者行预防性造口。随访时,中位距离肛缘 3cm 处发现中位长度为 4cm 的狭窄。89.1%的患者接受内镜扩张治疗,9.1%的患者需要再次手术。总的来说,49.1%的患者通过扩张治疗获得了持续的狭窄缓解,45.4%的患者需要再次干预。最后随访时,72.7%的患者无造口。多变量分析显示,良好的功能状态、无吻合口漏和短节段狭窄是狭窄缓解的预测因素。
内镜扩张是一种有效的一线治疗方法,对于保守治疗失败的患者,再次吻合是一种挽救措施。不良的功能状态、吻合口漏和更大的狭窄长度可能预示着狭窄缓解方面的不良结局。